TOT BIOPHARM International Company Limited
Equities
1875
HK0000545266
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.65 HKD | +8.55% | +6.45% | -16.24% |
Mar. 15 | TOT BIOPHARM International Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Nov. 10 | TOT Biopharm's Loss Narrows in January-September Period | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-16.24% | 150M | |
+2.90% | 108B | |
+9.30% | 104B | |
+6.58% | 23.66B | |
-12.18% | 22.1B | |
-3.29% | 19.71B | |
-35.36% | 18.2B | |
-13.33% | 16.19B | |
+3.86% | 13.72B | |
+33.13% | 12.22B |
- Stock
- Equities
- Stock TOT BIOPHARM International Company Limited - Hong Kong S.E.
- News TOT BIOPHARM International Company Limited
- TOT Biopharm International Unit Grants Kexing License to Commercialize Cancer Drug Overseas